DECENTRALIZED MEDICINE #71: NANOPTHALMUS

The Decentralized Model’s Core Principles Applied to Nanophthalmos ​Nanophthalmos as a Consequence of Disrupted Bioelectric Buoyancy I belie

The Decentralized Model’s Core Principles Applied to Nanophthalmos

Embryogenic and Transgenerational Roots of this condition are more important to comprehend. As a developmental disorder, nanophthalmos originates during embryogenesis, where photoreceptor-bioelectric signaling sculpts the optic vesicle from neural ectoderm. Disruptions here, via maternal nnEMF/blue light, alter proton tunneling in mitochondria, deuterium fractions, and mitochondrial water, leading to thickened sclera and reduced vitreous volume.

This is transgenerational: Maternal and grandmaternal pre-pregnancy histories (e.g., ALAN exposure, deuterium-rich diets) load fetal mtDNA with heteroplasmy, passing epigenetic tags via POMC-melanin pathways. Much evidence supports this; light wavelengths during pregnancy influence fetal eye formation, with longer wavelengths (e.g., red) reducing viability in models. In utero circadian mistiming exacerbates craniosynostosis (premature skull fusion) and relative hydrocephalus, compressing optic structures and amplifying buoyancy loss. Prenatal stressors like nanoparticles or radiation show similar transgenerational effects on neurodevelopment, mirroring nanophthalmos’ genetic background.

Unified Implications: From Chaos to Order in Nanophthalmos

In this model, nanophthalmos is a dissipative failure; mitochondria are unable to transform light into ordered growth due to éR imbalances in the embryo. Hydrated melanin dampens starlight into bioelectric whispers, but modern life dehydrates it, spiking conductivity and entropy. To curate reversal: Prioritize AM sunlight for DDW production, shun ALAN/nnEMF, and trace generational light histories. This upgrades centralized views (e.g., pure genetics) with quantum biology: Light sculpts eyes via melanin, answering Schrödinger’s “What is life?” as a symphony of resisted energy. Accuracy notes: Genetic links (e.g., MYRF) are established, mitochondrial ties to eye disorders supported, but deuterium/bioelectric specifics are excellent in describing the biophysics of this disease.

Nanophthalmos as a Consequence of Disrupted Bioelectric Buoyancy

I believe nanophthalmos emerges when bioelectric gradients and mitochondrial water production fail to sustain eye growth. I believe transgenerational blue light exposure is behind many eye diseases. This blog covers another one. This is a process that is thermodynamically linked to brain and skull development. This is why it is associated with some developmental syndromes. My model’s focus on nnEMF/blue light damaging melanopsin, mtDNA, and the glyoxalase system aligns with this, as dehydrated melanin increases conductivity, disrupting the trillionth-amp DC current at cytochrome c oxidase. The GOE’s oxygen-driven evolution favored melanin hydration and DDW (deuterium-depleted water) production for bioelectric precision, but modern deuterium loading (via the kinetic isotope effect, KIE) slows proton motion in the Grotthuss mechanism, stunting ocular morphogenesis. In utero, mistiming can create a relative craniosynostosis and hydrocephalus situation during morphogenesis that can amplify this condition by altering CSF buoyancy and redox signaling, creating a perfect storm for nanophthalmos.

My framework highlights:

Mitochondrial Water Production and Bioelectric Currents: Mitochondria produce water at cytochrome c oxidase, generating a bioelectric DC current (approximately one trillionth of an amp) for tissue regeneration. Disruptions in electrical resistance (éR) impair regeneration and development, destroying photorepair mechanisms you have already learned about in this series.

Melanin Hydration and Conductivity: Hydrated melanin dampens bioelectric currents, whereas dehydrated melanin (resulting from nnEMF or blue light) becomes conductive, amplifying aberrant signals and driving pathology.

Watch this to make it clear.  https://www.youtube.com/watch?v=zCGnMY9FSNg

nnEMF and Blue Light as Stressors: These damage melanopsin, mtDNA, and the glyoxalase system, increasing ROS/RNS, ultraweak biophotons, and methylglyoxal, disrupting cellular homeostasis.

Hypothalamic and Autonomic Dysregulation: The hypothalamus regulates ocular development and autonomic tone via melanopsin signaling, which will cause disruptions affecting eye growth.

Developmental Photo-Bioelectricity: Photo-bioelectric gradients, influenced by éR, guide morphogenesis (e.g., eye development), with nnEMF/ALAN altering these gradients, causing microopthalmia.

As a developmental disorder, nanophthalmos likely originates during embryogenesis, which is why I think this is fundamentally a transgenerational disease. I believe knowing your mother and grandmother’s pre-pregnancy and pregnancy histories would be quite germane. This is because this is where photo-bioelectric signaling plays a critical role in eye formation. The etiology for this, based on decentralized medicine ideas, would be as follows.

Can the COVID jab cause this disease? Yes, it can because it affects eye development, as the spike protein destroys the signal and increases the noise in stem cell depots that grow the eye.

COVID-19 mRNA Shots have been shown to destroy 8.4% of Non-Renewable Eye Cells in 75 days, according to this new study above. It found irreversible structural damage to the corneal endothelium of the eye in healthy young adults following Pfizer’s mRNA injection. No wonder many vaccinated individuals experience vision problems in the anterior chamber after receiving the shots.

Predictions for Nanophthalmos Etiology

  • nnEMF and Blue Light Disrupt Bioelectric Gradients During Eye Development:
    • Prediction: Prenatal or early postnatal exposure to nnEMF and blue light disrupts bioelectric gradients critical for eye morphogenesis, leading to arrested eye growth in nanophthalmos.
    • Mechanism: During embryogenesis, bioelectric potentials (driven by ion channels and mitochondrial éR) guide cell proliferation, migration, and differentiation in the optic vesicle and lens placode. nnEMF and blue light, absorbed by melanopsin in developing retinal ganglion cells (RGCs), likely from maternal retinal tissues, impair melanopsin signaling to the hypothalamus. This disrupts circadian and autonomic regulation of eye growth factors (e.g., VEGF, TGF-β). nnEMF and blue light ruin the germ line and load it with deuterium. It’s the KIE effect that affects proton motions that are supposed to happen seamlessly. One atom of deuterium affects the motions of 96 H+ in this optic placode. Not a good thing when you understand the Grotthuss mechanism in the matrix of mitochondria. Protons matter; it is not just about electrons in morphogenesis.

      Want some quick Grotthaus Wisdom from Nature? Here’s a decentralized fix no centralized MD thought to give: live more like our ancestors: eat fresh and local food, soak up sunlight, and ditch the tech overload and do it grounded to keep deuterium low and the Z-Z highway open. What I want you to know is that how protons move in your body isn’t just a nerdy detail; it’s a significant biophysical issue for your health. Centralized clinicians have no idea about this science. Normally, your cells use the fast Z-Z highway of Grotthuss to keep energy humming, and that’s how humans thrived in their evolutionary past with clean diets and natural living, and their momma had no sticky germline eggs. The Z-Z Grotthaus pathway = Fast energy, great electrical resistance in cells = a healthy you and your kids’ eyes are not small. It works best with a clean lifestyle and minimal exposure to blue light or non-EMF. Sunlight optimizes the Z-Z pathway.

      E-Z-E = Slow energy, struggling with you. This phenomenon occurs more frequently with modern junk food, LED lights, WiFi stress, and energy vampires.

      Cut the crap (bad food, artificial blue light, nnEMF), get sunlight, be like the sphinx every AM, and your body’s energy trucks will roll better. It is not rocket science. It is brain surgery without a scapel.

      Simultaneously, nnEMF damages mtDNA, likely affecting DDW production in the ocular placode in ocular precursor cells, reducing mitochondrial water production and lowering éR, which alters the bioelectric gradients needed for proper axial length expansion.

    • In Utero Warburg Effect and Ocular Redox Timing

      My interpretation of the Warburg effect as a circadian clock braking mechanism, which uses glucose, aligns with nanophthalmos morphologically. The retina’s natural Warburg metabolism limits ROS/RNS under light stress, and nanophthalmic eyes may over-rely on this due to nnEMF-induced pseudo-hypoxia. Craniosynostosis and hydrocephalus disrupt mitochondrial-nuclear proximity, favoring glycolysis over the TCA cycle, and reducing water and CO2 production. My thesis would argue that cold exposure, which enhances endogenous UV-like emission via UPEs, could reset this timing, promoting proper eye elongation that is now lost in modern humans without a winter context.

      Outcome: The eye fails to elongate correctly, resulting in a small axial length, a small cornea, and a thickened sclera/choroid, which are the phenotypic characteristics of nanophthalmos.

  • Dehydrated Melanin in the Retina and Choroid Impairs Developmental Signaling:

    Prediction: Dehydration of melanin in the developing retina, RPE (retinal pigment epithelium), and choroid, caused by nnEMF and blue light, disrupts bioelectric signaling, arresting eye growth.

    Mechanism: Melanin in the RPE and choroid, present early in eye development, regulates bioelectric currents by maintaining hydration-dependent resistance. nnEMF and blue light reduce mitochondrial water production (via mtDNA damage), dehydrating melanin and increasing its conductivity (per my Popular Science reference on eumelanin from blogs). This amplifies ultraweak biophotons and ROS/RNS, overstimulating developmental pathways (e.g., Wnt, Hedgehog) that rely on precise photo-bioelectric cues.

    Eye Development TIME SCALE

    Week 3: Optic grooves, which are the first sign of eye development, appear from the developing forebrain.

    Weeks 3-10: The optic vesicles, formed from the optic grooves, begin to evaginate and induce changes in the surface ectoderm for lens formation. This period also involves the invagination of the optic cup and the formation of the optic stalk.

    Weeks 6-8: The optic fissure, a transient structure in optic nerve development, begins to fuse.

    By week 7: The optic fissure is completely closed.

    Around week 10, the eyelids fuse together, although they will reopen later to protect ongoing brain organogenesis. A failure to fuse the optic fissure on time is one of the things associated with developmental brain disorders tied to unquenched UPEs. Timescale errors in eye development will alter the following signals: melanin dehydration, bioelectric signals, vascular dysfunction, link neurulation, craniosynostosis, hydrocephalus, and tumors in a disrupted GOE-evolved system. The proper light drives optimal eye development. Light malnutrition gives us this condition.

Melanin and vascular dynamics are linked to timescale errors, which alter the morphological timing of the eye. Building on my melanopsin-in-arteries insight, dehydrated melanin in ocular vessels (e.g., central retinal artery) under nnEMF/blue light impairs vasodilation, reducing oxygen delivery to the optic vesicle. This links craniosynostosis (via CSF pressure) and hydrocephalus (via buoyancy overload) to nanophthalmos, as poor perfusion stunts scleral and corneal growth. My thesis would suggest that cooling with grounding and AM sunrise restores melanin hydration, enhancing vascular tone and eye development in children, which is critical for parents to begin.

Deuterium’s KIE ruins this embryology big time. The resulting aberrant currents inhibit scleral and corneal expansion while promoting excessive choroidal/scleral thickening. Water’s role in reducing entropy and mass depends wholly on low deuterium levels for efficient proton tunneling. In nanophthalmos, nnEMF’s KIE effect loads deuterium, slowing Grotthuss motion and disrupting bioelectric currents. Any situational in utero craniosynostosis and/or hydrocephalus exacerbate this by altering CSF composition, reducing mitochondrial DDW production. My decentralized approach, featuring fresh food, sunlight, and grounding, aligns with GOE-evolved hydration strategies to support eye growth.

Outcome: The resulting eye in the child/adult would remain small, with a thickened sclera and choroid, leading to nanophthalmos and its associated hyperopia.

Hypothalamic Dysregulation Alters Ocular Growth Factors:

Prediction: nnEMF and blue light impair hypothalamic control of ocular development, reducing growth factor signaling and contributing to nanophthalmos.

Mechanism: The hypothalamus, via the suprachiasmatic nucleus (SCN) and retinohypothalamic tract, regulates circadian rhythms and autonomic tone, influencing eye development through hormones and growth factors (e.g., IGF-1, dopamine). Melanopsin damage in the developing retina (or maternal retina during pregnancy) disrupts this pathway, altering hypothalamic outputs in the growing child and adult.  This could lead to problems, but it also could be offset by the other eye.  These actions in the affected eye reduce dopamine (a growth inhibitor in the retina) and IGF-1 (a growth promoter), stunting axial elongation. nnEMF’s effect on the glyoxalase system further increases methylglyoxal, which glycates developmental proteins and impairs tissue expansion.

Outcome: Reduced eye growth leads to a classic phenotypic small anterior chamber and axial length, increasing the risk of angle-closure glaucoma in nanophthalmos.

Ultraweak Biophotons and ROS/RNS Disrupt Cellular Differentiation:

  • Prediction: Overproduction of ultraweak biophotons and ROS/RNS in the developing eye, driven by nnEMF and blue light, disrupts cellular differentiation and growth, contributing to nanophthalmos. This means those with this condition see the world with a different perspective from others due to the visual changes. This is due to changes in dopamine, melatonin, and GABA in the eye that regenerate all our photoreceptors. Consciousness in these patients differs from that of humans with normal eyes as a result.
  • Vascular Perfusion Metrics: Reduced blood flow velocity in ocular arteries (via Doppler ultrasound) in nanophthalmos patients correlates with nnEMF exposure, reflecting melanopsin dysfunction. Elevated deuterium in ocular tissues (via mass spectrometry) in nanophthalmos cases indicates impaired Grotthuss efficiency, a transgenerational marker from maternal exposure.
    • Mechanism: As I’ve often cited (Roeland Van Wijk and Fritz Popp), ultraweak biophotons reflect cellular health. In the developing eye, nnEMF and blue light damage mtDNA, increasing biophoton emission and ROS/RNS. This oxidative stress alters gene expression (e.g., PAX6, SOX2) critical for lens and retina formation, while biophotons overstimulate pathways like Notch, disrupting cell fate decisions. The result is reduced proliferation of corneal and scleral cells, leading to a small eye.

      Prevention: Hibernation-Like Intervention: Prenatal cold exposure or simulated hypoxia increases ascorbic acid and endogenous UV, enhancing aquaporin proton tunneling and eye growth, reducing nanophthalmos severity.

      Outcome: Impaired differentiation and growth result in the microphthalmia features of nanophthalmos, which are predisposed to glaucoma due to anterior segment crowding and more eye floaters and anterior chamber diseases.

    Warburg-Like Metabolic Shift in Ocular Precursor Cells:

    Prediction: Ocular precursor cells under nnEMF/blue light stress will certainly exhibit a Warburg-like redox shift, reducing oxygen use and impairing eye growth.  This is related to the Great Oxygen Holcaust that nnEMF causes.

    • Historical Context (Great Oxygen Holocaust):

      The Great Oxygenation Event forced adaptations (e.g., mitochondria, heme proteins) to manage oxygen toxicity. Modern nnEMF and ALAN mimic this oxygen catastrophe, which acts to dehydrate ALL heme-containing proteins like cytochrome P450scc while simultaneously disrupting regenerative processes that were optimal 65 million years ago.  This is why the normal adult retina still employs Warburg metabolism, which explains the absence of arterial cascades in the foveal region of the retina.

One should expect hormone abnormalities with this condition.  The non-affected eye could overcome this.  But more than likely, this will lead to lower-than-usual levels based on age. Why? Dehydrated melanin (from nnEMF/ALAN) disrupts this, impairing steroidogenesis via cytochrome P450scc, which converts cholesterol to pregnenolone (the precursor to cortisol, testosterone, and other steroids).  Pregnenone steal syndrome is likely due to defects in T3 and Vitamin A from opsin damage linked to melanopsin damage. nnEMF causes a TBI-like effect due to the electrocution-like impact resulting from the lack of hydrated melanin in the anterior and posterior pituitary regions, which reduces vasopressin and ACTH, impairing ocular development in nanophthalmos.

nnEMF disrupts the hypothalamus-pituitary axis, lowering vasopressin (from the posterior pituitary) and ACTH (from the anterior pituitary). Vasopressin regulates water balance, which is crucial for melanin hydration and DDW production, while ACTH stimulates adrenal cortisol production via the P450scc enzyme. Reduced vasopressin dehydrates melanin sheets in the retina/choroid, amplifying bioelectric dysfunction, while low ACTH translation from POMC exacerbates pregnenolone steal syndrome, limiting cortisol for growth. This aligns with Neil Armstrong’s post-moon symptoms (pseudotumor cerebri, optic nerve swelling, pituitary failure) due to nnEMF exposure.  It also explains the space findings seen in all astronauts who share many of these conditions’ symptoms.

I would also expect arterial abnormalities in the eye due to the melanopsin effect, since melanopsin is known to be present in all arteries.  Why?

Melanopsin in Arteries:

  • Melanopsin, traditionally known for its role in circadian regulation in retinal ganglion cells, has been identified in vascular smooth muscle and endothelial cells across various arteries, including those in the eye (e.g., the central retinal artery and ciliary arteries). It acts as a photoresponsive receptor, modulating vascular tone, blood flow, and oxygen delivery in response to light exposure.

Melanopsin in arterial walls regulates vasodilation and vasoconstriction in response to light cues, ensuring proper blood flow for eye growth. nnEMF and blue light (400-550 nm) damage melanopsin, impairing its signaling to the hypothalamus and autonomic nervous system (via the retinohypothalamic tract). This disrupts vascular tone, reducing oxygen and nutrient delivery to the developing optic vesicle, retina, and sclera. Concurrently, mtDNA mutations in cytochrome c oxidase (due to heteroplasmy) lower DDW production, dehydrating melanin in vascular tissues and amplifying ROS/RNS, further damaging endothelial cells. The resulting arterial abnormalities (e.g., hypoperfusion, abnormal vessel branching) stunt eye elongation.

        • Disruption of melanopsin signaling (e.g., by nnEMF or blue light) alters vascular dynamics, affecting ocular perfusion and development.  This is why we see vascular proliferation in diabetic retinopathy. Nanophthalmos in humans is primarily an ocular disorder but can be associated with several ocular diseases, including high-angle glaucoma, uveal effusion syndrome, retinal detachment, and cataracts. It is also linked to genetic syndromes such as Retinitis Pigmentosa and foveoschisis, and specific conditions like Macaulay-Shek-Carr syndrome, which involves retinal degeneration. I believe this shows us how mtDNA damage can alter epigenetics, which can also affect DNA and cause these unusual diseases. What am I saying clearly here? Many genetic diseases are not really genetic diseases, and this means we can help those people if we understand the decentralized mechanisms behind these diseases. Retinitis Pigmentosa, foveoschisis, and retinoblastoma are examples.

          Mechanism: Similar to my glaucoma and cancer models, nnEMF and blue light lower Δψ and éR in developing ocular cells, shifting metabolism toward glycolysis (the Warburg effect). Oxygen becomes toxic (my “oxygen allergy” concept), reducing mitochondrial efficiency and water production. This impairs the photo-bioelectric currents needed for cell proliferation and tissue expansion, stunting eye development.

          Prediction: nnEMF and blue light deplete NO in the developing eye, impairing stem cell depots used to grow the eye normally and contributing to nanophthalmos.

          Mechanism: NO, a key signaling molecule, regulates stem cell proliferation and differentiation in the optic vesicle and lens placode. Blue light destroys NO by disrupting heme-based cytochromes (e.g., via the liberation of vitamin A tied to opsin biology), while nnEMF-induced oxidative stress further depletes NO. This impairs stem cell-driven growth of ocular tissues, resulting in reduced axial elongation and corneal expansion. The lack of NO also disrupts the POMC/melanin complex, as NO signals the oxidation states of hemoglobin, which in turn influence melanin hydration and hormone production.

          The lack of NO (destroyed by blue light) further impairs POMC signaling, as NO is required to transmit hemoglobin oxidation states to this complex.

          Outcome: Reduced stem cell activity leads to a small eye with a shallow anterior chamber, characteristic of nanophthalmos, and increases glaucoma risk due to anatomical crowding.

    Methylglyoxal and AGE Accumulation in Developing Tissues:

    Prediction: The nnEMF-induced glyoxalase system disruption increases methylglyoxal, glycating ocular proteins, and arrests eye development.

    Mechanism: As with cataracts and glaucoma, nnEMF affects transition metals in the glyoxalase system, depleting glutathione and elevating methylglyoxal. In the developing eye, this glycates structural proteins (e.g., collagen in the sclera, cornea), stiffening tissues and impairing growth. Glycation also disrupts signaling pathways (e.g., FGF, BMP) required for axial elongation.

    Outcome: As a result, the eye fails to grow properly, resulting in the small, hyperopic eye of nanophthalmos, with glycation contributing to scleral thickening.

Integration with My Decentralized Medical Thesis

​The Legacy of the GOE variable oxygen fluctuation ties nanophthalmos to an in utero GOE-alteration affecting buoyancy and redox adaptations, most likely driven by modern nnEMF/blue light mimicking an “oxygen Holocaust.” Amniotic fluid and CSF changes in utero are likely transiently disordered during the morphogenesis of the eye and brain to cause this condition.

My model predicts that nanophthalmos is not solely a genetic disorder, as textbooks and centralized medicine suggest, but a photo-bioelectric and environmental condition driven by nnEMF and blue light exposure during critical developmental windows (prenatal or early postnatal).

 

This aligns with my decentralized medicine approach, emphasizing environmental factors (light, EMF) over genetic determinism. As a central regulator of ocular development, the hypothalamus links these stressors to disrupted photo-bioelectric signaling. At the same time, melanin dehydration and mitochondrial dysfunction exacerbate the effects, resulting in the classic phenotype.  The earlier this disease is treated, the fewer the symptoms should be, as proper therapy in childhood could potentially regrow the eye, similar to Dr. Becker’s work in fingertip regrowth, as documented in a three-year-old.

Dr. Robert Becker documented the regrowth of a three-year-old’s fingertip, attributing it to a bioelectric current (via silver ions and low-level currents) that stimulated stem cell activity and tissue regeneration. This suggests that early intervention with bioelectric therapies could similarly regrow ocular tissues in nanophthalmos by restoring the trillionth-amp DC current produced by mitochondrial water at cytochrome c oxidase.

This framework challenges conventional centralized models by suggesting that nanophthalmos and its associated glaucoma risk stem from modern environmental mismatches rather than inherited mutations alone.

 

Testable Predictions for this Condition

  • Environmental Correlation: Higher incidence of nanophthalmos in populations with prenatal exposure to non-ionizing electromagnetic fields (nnEMF)/ALAN (e.g., maternal screen use, urban EMF levels, higher latitudes, and indoor living).
  • Melanin Hydration: Reduced melanin hydration in the RPE/choroid of nanophthalmic eyes, measurable via imaging or biopsy.
  • Mitochondrial Markers: Lower Δψ and elevated ultraweak biophotons release in ocular tissues from nanophthalmos patients with nnEMF exposure history.
  • Therapeutic Response: Prenatal UV-A exposure or maternal DDW (deuterium-depleted water) reduces nanophthalmos risk by supporting melanin hydration and mitochondrial éR to stimulate the growth of the globe in childhood
  • Glyoxalase System: Elevated methylglyoxal and AGEs in the sclera/choroid of nanophthalmic eyes, linked to nnEMF exposure. Someday, specialized spectroscopic OCT could prove this.

SUMMARY

Eye development is inherently linked to brain development, as the optic structures originate from the forebrain’s diencephalon. The morphological timeline of both organs emphasizes key milestones up to around week 10, as eye formation largely completes by then, though both systems continue maturing.

Nanophthalmos, characterized by a phenotypically small but structurally normal eye, represents a spectrum of developmental disorders in which the axial length is compromised, often leading to hyperopia, angle-closure glaucoma, and retinal issues. In the decentralized medicine framework, this condition arises not from isolated genetic mutations but as a consequence of disrupted bioelectric buoyancy, which is a thermodynamic interplay between mitochondrial water production, melanin hydration, and photo-bioelectric gradients that fails to sustain proper eye growth. This disruption is intrinsically linked to brain and skull development, where modern stressors, such as non-native electromagnetic fields (nnEMF) and blue light (artificial light at night, ALAN), damage key systems, including melanopsin, mitochondrial DNA (mtDNA), and the glyoxalase pathway.

The result?

Dehydrated melanin shifts from a dampening resistor to a hyper-conductive state, obliterating the precise one-trillionth-amp DC bioelectric current essential for tissue renovation at cytochrome c oxidase. Drawing on evolutionary lessons from the Great Oxidation Event (GOE), where oxygen-driven adaptations favored hydrated melanin and deuterium-depleted water (DDW) for bioelectric precision, contemporary deuterium loading via the kinetic isotope effect (KIE) slows proton tunneling in the Grotthuss mechanism, thereby stunting ocular morphogenesis.

In utero, this manifests as a relative craniosynostosis-hydrocephalus dynamic, where mistimed cerebrospinal fluid (CSF) buoyancy and redox signaling create a perfect storm for nanophthalmos. This integration applies the decentralized model’s core principles, with light as the primary sculptor of biology, melanin as the quantum ampere, mitochondria as dissipative structures, and éR (energy resistance) as the balancer of transformation versus dissipation, to explain nanophthalmos as a transgenerational, embryonic failure. I outline the framework above, etiology, and implications, weaving in evidence from bioenergetics and developmental biology.

Perioperative Complications

Patients with nanophthalmos are at higher risk of complications during eye surgeries, such as cataract surgery or retinal surgery, including malignant glaucoma, uveal effusion, and nonrhegmatogenous retinal detachment.

CITES

https://www.researchgate.net/publication/367538581_Optic_cup_morphogenesis_across_species_and_related_inborn_human_eye_defects

https://www.researchgate.net/publication/335176649_The_Molecular_Basis_of_Human_Anophthalmia_and_Microphthalmia

 

DECENTRALIZED MEDICINE #70: PTYERGIUM AND CONJUNCTIVITIS

On page 61 of John Ott’s masterpiece, Health & Light, he wrote the following:   WHAT DOES DECENTRALIZED MEDICINE SAY ABOUT THIS NOW? Non

On page 61 of John Ott’s masterpiece, Health & Light, he wrote the following:

WHAT DOES DECENTRALIZED MEDICINE SAY ABOUT THIS NOW?

None of the opsin proteins of the eye, brain, or skin was discovered in 1969.

The 1969 experiment by Philip Salvatori revealed that UV light plays a significant role in the eye’s physiology, particularly in pupil dynamics. UV-transmitting contact lenses cause greater pupil constriction in sunlight compared to non-UV-transmitting lenses.

My slides above highlight the non-linear absorption of UV light by the eye (e.g., 92% at 300 nm by the cornea) and the piezoelectric effect of eye collagen, which amplifies small UV stimuli. This suggests that UV light influences photoreceptor mechanisms beyond visible light, a finding that predates the discovery of neuropsin in the cornea and skin and melanopsin in the eye and brain. The second slide further expands on this by detailing how neuropsin, sensitive to 380 nm UV light, integrates with the mTOR pathway and circadian clock mechanisms, affecting metabolic flux, protein translation, and clock periodicity. These insights reveal a complex interplay between UV light, ocular physiology, and systemic health, with significant implications for conditions like pterygium.

1. Neuropsin’s Role in Photorepair, mTOR, and Circadian Regulation

The second slide illustrates that neuropsin, activated by 200–380 nm UV light, triggers a cascade involving SIRT1, NAD+, and NAMPT, which regulates metabolic flux (e.g., changes in glucose, ATP/AMP, adenosine, O₂, glucocorticoids, and catecholamines). This cascade influences the mTOR pathway, a key regulator of cellular growth, metabolism, and protein translation. Specifically:

  • mTOR Activation at 380 nm: Neuropsin activation by UV light at 380 nm enhances mTOR signaling, thereby optimizing processes such as gluconeogenesis, mitochondrial biogenesis, oxidative phosphorylation, amino acid turnover, lipogenesis, and bile acid synthesis. These processes are crucial for maintaining cellular energy balance and repairing tissue damage, such as in the cornea and conjunctiva. You can see that eye health professionals are unsure of the meaning of these signals. This means neither did the kid’s parents. How can you protect your kids when the doctors are ignorant? The child below has conjunctivitis, and this has major implications for future diseases.

Circadian Clock Regulation: Neuropsin also interacts with the circadian clock at 380 nm, influencing clock genes (CLOCK, BMAL1, PER, CRY) and their downstream targets (REV-ERB, ROR, PPARα, PGC1α). This regulation ensures that cellular processes are synchronized with the light-dark cycle, particularly through morning sunlight exposure, which provides UV and near-UV light to reset the clock.

Protein Translation via IR-A (600–1000 nm): The slide also notes that infrared-A (IR-A) light (600–1000 nm) further modulates protein translation through pathways involving AMPK, LKB1, and FBXL3/CRY, complementing the UV-driven effects of neuropsin.

The 1969 experiment from Ott’s book showed that UV light influences pupil size, likely through a photoreceptor mechanism in the iris or cornea. We now know that neuropsin in the cornea is sensitive to UV light at 380 nm, as indicated by the slides above. This suggests that neuropsin is the photoreceptor responsible for UV-driven pupil constriction, likely by signaling through SIRT1 and NAD+ to modulate local metabolic responses in the iris. This also has significant implications for the anterior chamber of the eye regarding heteroplasmy. Furthermore, the activation of the mTOR pathway by neuropsin enhances cellular repair in the cornea and iris, thereby protecting against UV-induced damage. Might this be why so many people develop cataracts today? They have blocked the ability to utilize this reflex. The regulation of the circadian clock by neuropsin also implies that UV exposure in the morning (rich in 380 nm light) helps synchronize ocular and systemic rhythms, which could influence pupil dynamics and overall light sensitivity throughout the day.

Missed Opportunity: Centralized medicine and ophthalmology likely have overlooked neuropsin’s role in integrating UV light with mTOR and circadian pathways. This has led to an incomplete understanding of how UV exposure affects ocular health, particularly in relation to cellular repair (via the mTOR pathway) and circadian alignment (via clock genes). For example, patients with disrupted circadian rhythms (e.g., night shift workers) might experience exacerbated light sensitivity or ocular stress due to a lack of morning UV exposure, which neuropsin requires to activate protective mechanisms. This would manifest as early-onset conjunctivitis in children and later as cataracts in those over 40.

2. Pterygium as a Manifestation of Light Deficiency

The thesis on pterygium etiology needs to be reframed because this condition, traditionally attributed to UV overexposure due to light deficiency, particularly a lack of morning sunlight, is not supported by current evidence. This aligns with the second slide’s emphasis on neuropsin’s role in circadian regulation and cellular repair.

Mitochondrial Dysfunction: A lack of morning sunlight, which contains UV and near-UV light (250–380 nm), disrupts neuropsin signaling in the cornea and conjunctiva. This impairs mTOR-driven mitochondrial biogenesis and oxidative phosphorylation, leading to energy deficits in conjunctival cells. This is an early sign of eye degeneration in kids that could lead to early, unnecessary deaths. The resulting Warburg shift (a metabolic switch to glycolysis) causes oxidative stress, contributing to pterygium formation.

Circadian Misalignment: The absence of morning UV light also desynchronizes the circadian clock, as neuropsin fails to activate clock genes like CLOCK and BMAL1. This disrupts the rhythmic expression of protective genes (e.g., PPARα, PGC1α), essential for maintaining ocular tissue health and immune surveillance. Many eye and skin diseases in children are linked to this mechanism.

Vitamin D and Immune Dysregulation: Centralized medicine often recommends sun avoidance, which reduces vitamin D synthesis, a critical factor for immune function. This weakens immune surveillance in the conjunctiva, allowing fibroblast proliferation and pterygium growth in the eye. This is linked to a lack of UVB exposure and too little IRA/NIR exposure. Sunglasses are the largest culprit.

Paramagnetic Switch and Oxidative Damage: Poor light environments shift iron in heme proteins to the Fe³⁺ state, making oxygen toxic to ocular tissues. This exacerbates oxidative damage in the conjunctiva, particularly when UV exposure is imbalanced (e.g., excessive midday UV without morning red light to balance it).

Environmental Stressors: Wind, dust, water pollution in the oceans, and imbalanced UV exposure further stress the conjunctiva, compounding the effects of light deficiency.

Integration with Previous Decentralized Findings: The first slide noted that the cornea absorbs significant UV light (e.g., 92% at 300 nm), and the 1969 experiment showed that UV influences pupil size, suggesting a protective mechanism. However, if morning UV exposure is absent, neuropsin cannot activate mTOR or circadian pathways to repair corneal and conjunctival cells, leaving them vulnerable to damage. The piezoelectric effect of eye collagen, which amplifies small stimuli, might also exacerbate oxidative stress in the conjunctiva when UV exposure is imbalanced, as small amounts of midday UV could trigger disproportionate damage without the protective effects of morning light.

Missed Opportunity: You saw for yourself the nonsense excuse the optometrist gave the parent above on the child’s conjunctivitis. This is what happens when you are missing pieces of Nature’s recipes. Centralized medicine’s focus on UV overexposure as the sole cause of pterygium ignores the protective role of morning sunlight. Ophthalmology and dermatology have failed to recognize this.

  • Morning UV light, via neuropsin, activates mTOR and circadian pathways to enhance mitochondrial function and cellular repair in the conjunctiva, potentially preventing pterygium.
  • Sun avoidance deprives the eye of UV-driven protective mechanisms, such as vitamin D synthesis and melanin production, which could mitigate inflammation and fibroblast proliferation.
  • Mitochondrial dysfunction, driven by light deficiency, is a key driver of pterygium, yet ocular health protocols rarely address mitochondrial support or circadian alignment.

This came directly from Ott’s book.

3. Implications for Centralized Medicine, Ophthalmology, and Dermatology

Building on the decentralized integration of neuropsin, mTOR, and circadian mechanisms reveals additional oversights:

Misattribution of Pterygium to UV Overexposure: Centralized medicine’s dogma of sun avoidance has led to the mischaracterization of pterygium as solely a result of UV damage, ignoring the protective role of morning UV light in activating neuropsin, mTOR, and circadian pathways. This has prevented the development of light-based therapies, such as controlled morning UV exposure, for the prevention or treatment of pterygium.

Neglect of Morning Sunlight’s Protective Role: Ophthalmology has overlooked the importance of morning sunlight (rich in 380 nm UV light) in resetting circadian rhythms and enhancing cellular repair via neuropsin and mTOR. This explains why pterygium patients often have lifestyles limiting morning light exposure (e.g., indoor work, sun avoidance). Most surfers miss the morning light and tend to surf later in the day; those who miss the morning light are the ones who tend to develop pterygium. People who wear sunglasses have the highest incidence of this condition, in my experience. John Ott reported the same in his book.

Failure to Address Mitochondrial Dysfunction: The role of mitochondrial dysfunction in pterygium, driven by a lack of neuropsin-mediated mTOR activation, has been ignored. Therapies targeting mitochondrial health (e.g., via light exposure, antioxidants, or metabolic support) could be a novel approach to preventing or treating pterygium.

Incomplete Understanding of UV’s Systemic Effects: The connection between UV light, neuropsin, and systemic health (via circadian regulation and metabolic flux) has been underappreciated. For example, disrupted neuropsin signaling due to UV deficiency may contribute to systemic issues such as fatigue, mood disorders, or metabolic imbalances, which could exacerbate ocular conditions.

  • Lack of Personalized Light Exposure Guidelines: Individual variability in neuropsin expression, melanin levels, and circadian sensitivity suggests that light exposure recommendations should be tailored to individual needs. For instance, patients with lighter eyes or disrupted circadian rhythms might need more morning UV exposure to activate protective mechanisms. In contrast, individuals with high UV sensitivity may require a balanced exposure to avoid damage.

4. Broader Systemic Implications

The slide’s emphasis on circadian clock periodicity and metabolic flux highlights that UV light’s effects extend beyond the eye. Neuropsin’s activation of clock genes (CLOCK, BMAL1, PER, CRY) and downstream targets (REV-ERB, ROR, PPARα, PGC1α) suggests that morning UV exposure is critical for systemic health.

Circadian Health: A lack of morning UV light disrupts circadian rhythms, which could contribute to sleep disorders, mood disturbances, and metabolic diseases. This might indirectly worsen ocular conditions like pterygium by increasing systemic inflammation and oxidative stress.

Metabolic Balance: Neuropsin’s influence on mTOR and metabolic flux (e.g., gluconeogenesis, lipogenesis) indicates that UV deficiency could impair energy metabolism, affecting tissues like the conjunctiva that rely on robust mitochondrial function.

Immune Function: The circadian clock regulates immune responses, and UV-driven neuropsin signaling supports this process. Sun avoidance, by reducing neuropsin activation, weakens immune surveillance in the eye, contributing to conditions like pterygium.

Missed Opportunity: Centralized medicine has failed to integrate the systemic effects of UV light into ocular health protocols. For example, patients with pterygium benefit from decentralized interventions that address circadian misalignment, metabolic health, and immune function rather than focusing solely on the surgical removal of the growth. How can a change in light spectrum lead to disease and an early death? The slide below explains it.

5. Potential Therapeutic Approaches

The integrated understanding of UV light, neuropsin, mTOR, and circadian mechanisms suggests several therapeutic strategies:

  • Controlled Morning Light Exposure: Encouraging morning sunlight exposure (rich in 380 nm UV light) could activate neuropsin, mTOR, and circadian pathways, enhancing cellular repair in the cornea and conjunctiva, resetting circadian rhythms, and preventing conditions like pterygium.
  • Mitochondrial Support: Therapies that support mitochondrial function (e.g., antioxidants, CoQ10, or light-based interventions) could mitigate the Warburg shift and oxidative stress in pterygium.
  • Personalized Light Filters: Contact lenses or glasses could be designed to allow controlled amounts of 380 nm UV light to reach the cornea, activating neuropsin while filtering harmful midday UV levels.
  • Circadian-Based Interventions: Addressing misalignment through light therapy, sleep hygiene, and lifestyle changes could reduce systemic inflammation and support ocular health.
  • Vitamin D Supplementation: For patients who practice sun avoidance, vitamin D supplementation may help restore immune surveillance and reduce inflammation in the conjunctiva; however, nothing can replace the sun’s benefits.

SUNGLASSES: If you still think sunglasses, glasses, or contact lenses are OK, you’d better read the book Health and Light by Dr. John Ott. All of them lead to a version of the oxygen Holocaust in the central retinal pathways that can cause distal diseases in organs. You’ll find a passage about the carcinogenic effects of filtering natural light was found accidentally in a conversation Dr. John Ott had with Dr. Albert Schweitzer’s daughter. The conversation pertained to her experiences with her father at Lambarene, on the west coast of Africa, and the rate of cancer found among those people.

  • A 34-year-old former elite athlete who used to wear Oakleys while dressed in black in college, who was first introduced to video games and non-electromagnetic fields (EMF) in film studies at Ohio State, whose NFL career was ended by chronic injuries before it ever got started. Nobody saw the signs of low redox all the way back to HS to see why he died at 34. He then became an executive who had to use blue light devices to do his job. Now, he dies suddenly, and his friends are surprised. Do you see where the pieces fit? They are surprised by these young deaths instead of expecting them. How long will it take for researchers to realize that we can utilize the retinol/melanopsin cycle and an EEG with electronic screen refresh rates?

    http://bobbycarpenter.com/mike-kudla-a-friend-a-roommate-a-buckeye/

    SUMMARY

Integrating neuropsin, mTOR, and circadian clock mechanisms into the narrative reveals that UV light, particularly at 380 nm, plays a critical role in ocular and systemic health. Neuropsin’s activation by morning UV light enhances cellular repair (via mTOR), synchronizes circadian rhythms (via clock genes), and supports metabolic flux, all of which are essential for preventing conditions like pterygium. Centralized medicine, ophthalmology, and dermatology have missed the protective role of morning sunlight, the importance of mitochondrial function in ocular health, and the systemic effects of UV-driven circadian regulation. Pterygium, rather than solely a result of UV overexposure, is a manifestation of light deficiency driven by a lack of morning UV light, circadian misalignment, and mitochondrial dysfunction. By embracing sensible light exposure and addressing these underlying mechanisms, we can prevent and treat ocular conditions more effectively, challenging the sun-avoidance dogma of centralized medicine.

CITES